A-500359 A

a nucleoside antibiotic from Streptomyces griseus

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Inukai, Masatoshi: 1 article (03/2003)
2.	Ishii, Michiko Miyazawa: 1 article (03/2003)
3.	Muramatsu, Yasunori: 1 article (03/2003)

1.	Tuberculosis (Tuberculoses) 03/01/2003 - "As a single intravenous injection of A-500359 A at a dose of 500 mg/kg showed no toxicity in mice, it was suggested that the capuramycin derivatives might become candidates as novel therapeutic agents for various diseases caused by Mycobacteria including tuberculosis."

1.	capuramycin

1.	Intravenous Injections